FDA Drug Application (090528) for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE by TORRENT PHARMS

Back to FDA Applications sponsored by TORRENT PHARMS

Application Number090528
Product Number001
FormTABLET;ORAL
Dosage12.5MG;50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient LOSARTAN POTASSIUM4


Back to FDA Applications sponsored by TORRENT PHARMS